Genotec Manufacturing Softgels in China

LIVINGSTON, N.J.— MM2 Group Inc. announced its wholly owned subsidiary, Genotec Nutritionals Inc., entered into a strategic venture with Anshi Pharmaceutical (Zhongsan) Inc. to manufacture softgel capsules in Zhongsan City, China. The current capacity of the state-of-the-art plant is 1.5 billion capsules per year, with room to expand capacity to five billion softgels annually. According to the companies, the plant was designed and built according to the current GMP (good manufacturing practice) requirements, in compliance with U.S. and China standards.

Mark Meller, CEO, MM2, said: “We have already met with some of the largest users of sofgels in the nutritional supplement market. Our current focus is to supply large quantities of vitamin E capsules to several users. We are now negotiating supply agreements with various companies.” Meller added the company recently secured a $1.1 million order for its omega-3 fish oil softgels, and was added to the Frankfurt Stock Exchange, with the aim of broadening its shareholder base in Europe.

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines

Read Comments [1]